
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hypokalemia resident survival guide
Introduction
Overview
Overview
Hypokalemia is defined as plasma potassium concentration less than 3.5 mEq/L. Hypokalemia may present as ileus, muscle cramps, rhabdomyolysis, and polyuria. Electrocardiography findings may include U wave, flat or inverted T waves, prolonged QT interval, and ventricular ectopy.
Causes
Causes
Life Threatening Causes
Life-threatening conditions which may result in death or permanent disability within 24 hours if left untreated. Severe hypokalemia may be life-threatening and must be treated as such irrespective of the underlying cause.
Common Causes
Shown below is a table summarizing the different pathophysiological processes that can lead to hypokalemia.
| Trans-cellular shifts | Renal loss | GI loss | Increased hematopoiesis | Decreased intake of potassium | |
|
Subject is normo or hypotensive Associated with alkalosis
Variable acid/base status |
Subject is hypertensive
Secondary hyperaldosteronism
Non aldosterone increase in mineralcorticoid
|
Associated with metabolic acidosis Associated with metabolic alkalosis
|
|
|
Diagnostic Algorithm
Diagnostic Algorithm
Shown below is an algorithm depicting the possible laboratory findings and their interpretation.
| Hypokalemia [K+] < 3.5 | |||||||||||||||||||||||||||||||||||||||||||||||
| Order: ❑ 24 hours urinary K+ (UK) ❑ Transtubular potassium gradient (TTKG) | |||||||||||||||||||||||||||||||||||||||||||||||
| UK > 25-30 mEq/L/day TTKG > 7 | UK < 25 mEq/L/day TTKG < 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Renal loss of potassium | GI loss of potassium | ||||||||||||||||||||||||||||||||||||||||||||||
What is the blood pressure? | |||||||||||||||||||||||||||||||||||||||||||||||
| Normal or ↓ | ↑ | ||||||||||||||||||||||||||||||||||||||||||||||
| Check the acid/base status | Possible etiologies are: Primary aldosteronism Secondary aldosteronism Non aldosterone increase in mineralcorticoids | ||||||||||||||||||||||||||||||||||||||||||||||
| Acidemia | Alkalemia | Variable | |||||||||||||||||||||||||||||||||||||||||||||
| Check urinary chloride (UCl) | Hypomagnesemia | ↑ Aldosterone ↓ Renin | ↑ Aldosterone ↑ Renin | ↓ Aldosterone | |||||||||||||||||||||||||||||||||||||||||||
| UCl < 20 | UCl > 20 | Primary aldosteronism | Secondary aldosteronism | Non aldosterone increase in mineralcorticoids | |||||||||||||||||||||||||||||||||||||||||||
Management
Management
- Treat the underlying etiology.
- Potassium repletion for the deficit (for every 1 mEq/L decrease in potassium, there is 200 mEq loss of total body potassium):
- PO: 40 mEq KCL Q 4-6 hours
- IV (if urgent): 10 mEq/hour KCL
- Recheck potassium levels in 2-4 hours.
- Provide IV hydration if necessary.
Do’s
Do’s
- Avoid excessive potassium repletion, particularly in the cases of transcellual shifts of potassium that can be reversed when the initial cause of hypokalemia is treated.
- Treat low magnesium blood concentration.
Dont’s
Dont’s
- If hydration is needed, do not administer dextrose solutions because dextrose increases insulin which can causes intracellular shift of potassium, and further exacerbates hypokalemia.
References
References
- ↑ Bourke E, Delaney V (1994). “Prevention of hypokalemia caused by diuretics”. Heart Dis Stroke. 3 (2): 63–7. PMID 8199766.
- ↑ Wu C, Xin J, Xin M, Zou H, Jing L, Zhu C; et al. (2016). “Hypokalemic myopathy in primary aldosteronism: A case report”. Exp Ther Med. 12 (6): 4064–4066. doi:10.3892/etm.2016.3864. PMC 5228118. PMID 28101185.
- ↑ Torpy DJ, Mullen N, Ilias I, Nieman LK (September 2002). “Association of hypertension and hypokalemia with Cushing’s syndrome caused by ectopic ACTH secretion: a series of 58 cases”. Ann. N. Y. Acad. Sci. 970: 134–44. PMID 12381548.
- ↑ Choi HY, Ha SK (2013). “Potassium balances in maintenance hemodialysis”. Electrolyte Blood Press. 11 (1): 9–16. doi:10.5049/EBP.2013.11.1.9. PMC 3741441. PMID 23946760.
- ↑ Hebert SC (September 2003). “Bartter syndrome”. Curr. Opin. Nephrol. Hypertens. 12 (5): 527–32. doi:10.1097/01.mnh.0000088732.87142.43. PMID 12920401.
- ↑ Knoers NV, Levtchenko EN (2008). “Gitelman syndrome”. Orphanet J Rare Dis. 3: 22. doi:10.1186/1750-1172-3-22. PMC 2518128. PMID 18667063.
- ↑ Tetti M, Monticone S, Burrello J, Matarazzo P, Veglio F, Pasini B, Jeunemaitre X, Mulatero P (March 2018). “Liddle Syndrome: Review of the Literature and Description of a New Case”. Int J Mol Sci. 19 (3). doi:10.3390/ijms19030812. PMC 5877673. PMID 29534496.
- ↑ Asmar A, Mohandas R, Wingo CS (2012). “A physiologic-based approach to the treatment of a patient with hypokalemia”. Am J Kidney Dis. 60 (3): 492–7. doi:10.1053/j.ajkd.2012.01.031. PMC 4776048. PMID 22901631.
- ↑ Cheungpasitporn W, Suksaranjit P, Chanprasert S (February 2012). “Pathophysiology of vomiting-induced hypokalemia and diagnostic approach”. Am J Emerg Med. 30 (2): 384. doi:10.1016/j.ajem.2011.10.005. PMID 22169581.
- ↑ Bazerbachi F, Haffar S, Szarka LA, Wang Z, Prokop LJ, Murad MH, Camilleri M (November 2017). “Secretory diarrhea and hypokalemia associated with colonic pseudo-obstruction: A case study and systematic analysis of the literature”. Neurogastroenterol. Motil. 29 (11). doi:10.1111/nmo.13120. PMID 28580600.
- ↑ Sanchez Garcia S, Villarejo Campos P, Manzanares Campillo Mdel C, Gil Rendo A, Muñoz Atienza V, García Santos EP; et al. (2013). “Hypersecretory villous adenoma as the primary cause of an intestinal intussusception and McKittrick-Wheelock syndrome”. Can J Gastroenterol. 27 (11): 621–2. PMC 3816940. PMID 24199207.
- ↑ Krejs GJ (May 1987). “VIPoma syndrome”. Am. J. Med. 82 (5B): 37–48. PMID 3035922.
- ↑ Gill M, McCauley M (2015). “Psychogenic polydipsia: the result, or cause of, deteriorating psychotic symptoms? A case report of the consequences of water intoxication”. Case Rep Psychiatry. 2015: 846459. doi:10.1155/2015/846459. PMC 4320790. PMID 25688318.
- ↑ Nguyen FN, Kar JK, Verduzco-Gutierrez M, Zakaria A (2014). “A case of hypokalemic paralysis in a patient with neurogenic diabetes insipidus”. Neurohospitalist. 4 (2): 90–3. doi:10.1177/1941874413495702. PMC 3975788. PMID 24707338.
- ↑ Rushing JM, Jones LE, Carney CP (2003). “Bulimia Nervosa: A Primary Care Review”. Prim Care Companion J Clin Psychiatry. 5 (5): 217–224. PMC 419300. PMID 15213788.
- ↑ Liang CC, Yeh HC (2011). “Hypokalemic nephropathy in anorexia nervosa”. CMAJ. 183 (11): E761. doi:10.1503/cmaj.101790. PMC 3153553. PMID 21670105.
- _Genetic_and_Rare_Diseases_Information_Center_(GARD)_–_an_NCATS_Program_17-0|↑ “Hypokalemic periodic paralysis | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program”.
- ↑ Zydlewski AW, Hasbargen JA (October 1998). “Hypothermia-induced hypokalemia”. Mil Med. 163 (10): 719–21. PMID 9795553.
- ↑ Elisaf M, Liberopoulos E, Bairaktari E, Siamopoulos K (March 2002). “Hypokalaemia in alcoholic patients”. Drug Alcohol Rev. 21 (1): 73–6. doi:10.1080/09595230220119282. PMID 12189007.
- ↑ Davis SM, Maddux AB, Alonso GT, Okada CR, Mourani PM, Maahs DM (2016). “Profound hypokalemia associated with severe diabetic ketoacidosis”. Pediatr Diabetes. 17 (1): 61–5. doi:10.1111/pedi.12246. PMC 4896141. PMID 25430801.
- ↑ Huang CL, Kuo E (October 2007). “Mechanism of hypokalemia in magnesium deficiency”. J. Am. Soc. Nephrol. 18 (10): 2649–52. doi:10.1681/ASN.2007070792. PMID 17804670.
- ↑ Nielson CB, Duethman NC, Howard JM, Moncure M, Wood JG (2017). “Burns: Pathophysiology of Systemic Complications and Current Management”. J Burn Care Res. 38 (1): e469–e481. doi:10.1097/BCR.0000000000000355. PMC 5214064. PMID 27183443.
- ↑ Bates CM, Baum M, Quigley R (February 1997). “Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent”. J. Am. Soc. Nephrol. 8 (2): 352–5. PMID 9048354.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2] Iqra Qamar M.D.[3]
